AXSOME THERAPEUTICS
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where current treatment options are limited or inadequate. Axsome has a balanced portfolio of clinical development stage as well as research stage products. Axsome Therapeutics aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. While the focus of the company is on developing its internally derived product candidates, Axsome also evaluates potential in-licensing opportunities to supplement its current portfolio.
AXSOME THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.axsome.com
Total Employee:
251+
Status:
Active
Contact:
+1 (212) 203-5072
Email Addresses:
[email protected]
Total Funding:
431.99 M USD
Technology used in webpage:
HSTS IPv6 CrUX Top 50m Common Name Invalid Microsoft CloudFront Amazon Route 53 DigiCert SSL Akamai Hosted Visual Studio
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-28 | SUNOSI | SUNOSI acquired by Axsome Therapeutics | 53 M USD |
Official Site Inspections
http://www.axsome.com Semrush global rank: 1.98 M Semrush visits lastest month: 10.63 K
- Host name: ec2-52-34-229-30.us-west-2.compute.amazonaws.com
- IP address: 52.34.229.30
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Axsome Therapeutics"
About Axsome - Axsome Therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms …See details»
Axsome Therapeutics - Crunchbase Company Profile
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where …See details»
Axsome Therapeutics Inc. - AnnualReports.com
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for …See details»
Axsome bounces back as FDA clears depression drug
4 days ago Axsome's drug was given a breakthrough designation from the FDA, reflecting the need for new treatment options in patients at increased risk of self harm or suicide, and was also given a priority ...See details»
Axsome Therapeutics - Overview, News & Similar companies
Oct 28, 2024 Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024 NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Axsome …See details»
Axsome Therapeutics - Contacts, Employees, Board Members
Organization. Axsome Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Chief Executive Officer Herriot …See details»
Axsome Therapeutics Inc: Overview - GlobalData
Axsome Therapeutics Inc (Axsome) is a biopharmaceutical company that develops and commercializes therapies for the treatment of central nervous system (CNS) disorders. The …See details»
Axsome Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Nov 1, 2024 NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies …See details»
Axsome Therapeutics - Craft
Oct 29, 2024 Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system (CNS) disorders. The Company …See details»
Axsome Therapeutics Provides Update on the New Drug …
NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of …See details»
Working at Axsome Therapeutics - Zippia
Mar 14, 2024 Zippia gives an in-depth look into the details of Axsome Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about …See details»
Axsome Therapeutics Reports First Quarter 2024 Financial
Effective May 1, 2024 , Axsome has contracted with a second large group purchasing organization (GPO) for potential formulary coverage of Auvelity. Pharmacy benefit managers …See details»
Axsome Therapeutics Voices its Commitment to Mental Health on …
Oct 10, 2022 “Axsome shares the World Health Organization’s vision of a world in which mental health is valued, promoted and protected. We are pleased to add our voice to raise awareness …See details»
Current Career Opportunities - Axsome Therapeutics
Axsome Therapeutics is seeking an experienced, dynamic commercial leader to manage the Trade and Distribution function and team. This individual will be responsible for the …See details»
Axsome Therapeutics Annual Report 2021 Form 10-K …
Axsome Therapeutics (AXSM) Historical Annual Reports 2016-2024 Year Report Size 2024 Axsome Therapeutics (AXSM) 10-K Annual Report - Feb 23rd, 2024 1.3mb ... incorporation or …See details»
Axsome Therapeutics, Inc. (AXSM) - Yahoo Finance Canada
Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based …See details»
Axsome Therapeutics Presents Data from Multiple Programs …
Oct 29, 2024 Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for central nervous system (CNS) conditions that have limited …See details»
Axsome Therapeutics Inc, AXSM:NMQ summary - FT.com
Dec 11, 2024 Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system …See details»
Axsome Connections Login
Welcome to the Axsome Speaker Network Welcome to the Axsome Speaker NetworkSee details»
Axsome Therapeutics (AXSM) Gets a Buy from Mizuho Securities
2 days ago Axsome Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $133.92, which is a 50.78% upside from current levels. In a report released on …See details»